SOLICITATION NOTICE
B -- Use of Limited Access Data Sets
- Notice Date
- 5/28/2002
- Notice Type
- Solicitation Notice
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, Contracts Operations Branch 6701 Rockledge Dr RKL2/6100 MSC 7902, Bethesda, MD, 20892-7902
- ZIP Code
- 20892-7902
- Solicitation Number
- NHLBI-PS-2002-082
- Response Due
- 6/7/2002
- Archive Date
- 6/22/2002
- Point of Contact
- Debra Hawkins, Chief, Procurement Section, Phone (301) 435-0366, Fax (301) 480-3345,
- E-Mail Address
-
dh41g@nih.gov
- Description
- The National Heart, Lung, and Blood Institute intends to negotiate, on a noncompetitive basis, with Maryland Medical Research Institute, 600 Wyndhurst Avenue, Baltimore, Maryland 21210-2425; Research Triangle Institute, Research Triangle Park, North Carolina 27709; University of Texas, 1200 Herman Pressler Drive, School of Public Health, Houston, Texas 77030; Columbia University, 2960 Broadway, New York, New York 10027-6902; University of Washington, 1107 NE 45th Street, Seattle, Washington 98105; Johns Hopkins University, 615 North Wolfe Street, Bloomberg School of Public Health, Baltimore, Maryland 21205-2179; University of North Carolina, 137 E Franklin Street, Chapel Hill, North Carolina 27514-4145; and University of Minnesota, Twin Cities, School of Public Health, 2221University Avenue, SE, Minneapolis, Minnesota 55414-3080, to reformat data sets received from completed clinical trials. Through competitive procedures contracts were negotiated to perform clinical trials for various research initiatives. Upon completion of those clinical trials data sets were delivered which compiled research data for use by other researchers in their own research investigations. Due to recent concerns about maintaining the confidentiality of patient data compiled as a result of in NHLBI's clinical trials, the data sets are to be modified to allow use of the data without inadvertently unveiling patient identities. The initial research institutions possess a unique familiarity with the clinical studies, and will be able to reformat the data sets systematically removing personal patient identifying information in a short period of time. In order for NHLBI to meet the confidentiality requirements and to make the data sets available to the research investigators in a timely manner, an award to any other source for this requirement would result in a substantial duplication of cost to the Government that is not expected to be recovered through competition. Background Information: The National Heart, Lung, and Blood Institute (NHLBI) has supported collection of data from participants in numerous clinical trials and epidemiologic studies. These well-characterized population samples represent rare and valuable scientific resources. In order to take full advantage of such resources and maximize their research value, it is important that data collected with public funds be made available, under appropriate terms and conditions, to the largest possible number of qualified investigators in a timely manner. Under contract-supported studies, a limited access data set is required as a contract deliverable to the NHLBI. In selected circumstances, such data sets also may be required of studies supported by cooperative agreements or grants. In preparing data sets for release the subject identifiers are removed. Variables that might lead to the identification of subjects, such as outliers, dates, and study site in the case of multi-center studies, are removed or collapsed into larger cells. Nevertheless, given enough information about an individual subject, coupled with publically available data, it may be possible to determine with reasonable certainty the identity of a particular subject. Therefore, the data are not truly "anonymized" and are only provided to investigators agreeing to adhere to established policies for distribution. Recently we have become aware that the data sets received before 2000 do not protect subject confidentiality to the extent we require under current NHLBI policy. Purpose and Objectives for the Procurement: The purpose of this acquisition is to reformat the data sets from a selection of previously conducted clinical trials to meet current confidentiality and documentation requirements. Period of Performance: The period of performance is from three (3) to twelve (12) months from the date of award, depending on the size and complexity of the data set. This acquisition is being conducted under simplified acquisition procedures and is exempt from the requirement of Federal Acquisition Regulations (FAR) Part 6, Competition Requirements. The North American Industry Classification System (NAICS) applicable to this requirement is 541710. This notice of intent is not a request for competitive proposals. Interested parties may identify their interest and capabilities in response to this requirement. The determination by the Government not to compete the proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct future competitive procurement. Responses to this announcement, referencing synopsis number NHLBI-PS-2002-082, may be submitted by mail to the National Heart, Lung, and Blood Institute, Contracts Operations Branch, Procurement Section, 6701 Rockledge Drive, Rockledge Building 2, Suite 6042, Bethesda, Maryland 20892-7902, Attention: Debra Hawkins . All responsible sources may submit a proposal, which, if timely received, shall be considered by the agency.
- Record
- SN00083945-W 20020530/020528213224 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |